Specifically, it highlights the association of B cells expressing CD20 and BAFF-R with reduced biliary tract cancer risk, while CD4RA+CD4+ T cells exhibit anti-tumor effects in biliary tract cancer. This evidence concerns the gene TNFRSF13C and neoplasm.